Literature DB >> 21625192

Oral squamous cell carcinoma: clinicopathological features in patients with and without recurrence.

Danielle Resende Camisasca1, Marcos Antônio Nunes Costa Silami, Júlia Honorato, Fernando Luiz Dias, Paulo Antônio Silvestre de Faria, Simone de Queiroz Chaves Lourenço.   

Abstract

AIM: To compare the clinicopathological profile of oral squamous cell carcinoma (OSCC) in groups with and without recurrence.
METHODS: Records of all patients who underwent surgery for primary OSCC at a single institution during 1999 were identified. Patient demographics, lesion site, clinical and pathologic stage, pathologic grading, pattern of invasion, lymphocytic infiltrate, perineural invasion, and treatment and survival data were collected. Descriptive statistics were calculated for each variable and survival was calculated using Kaplan-Meier and Cox models. Patients were divided into 2 groups: with (n = 25) and without (n = 28) recurrence.
RESULTS: Tongue (p = 0.02) and poorly differentiated (p = 0.04) tumors were associated with recurrence. Kaplan-Meier and Cox models revealed tobacco use and the absence of lymphocytic infiltrate to be associated with the poorest survival in recurrent OSCC.
CONCLUSION: The tumor site, tobacco use, and pathological features were involved in the recurrence of OSCC and should be taken into account for OSCC treatment and follow-up.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21625192     DOI: 10.1159/000328340

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  19 in total

1.  Correlation of MAGE-A tumor antigens and the efficacy of various chemotherapeutic agents in head and neck carcinoma cells.

Authors:  S Hartmann; U Kriegebaum; N Küchler; R C Brands; C Linz; A C Kübler; U D A Müller-Richter
Journal:  Clin Oral Investig       Date:  2013-02-21       Impact factor: 3.573

2.  Evaluation of a post-treatment follow-up program in patients with oral squamous cell carcinoma.

Authors:  Andre Peisker; Gregor Franziskus Raschke; Arndt Guentsch; Paul Luepke; Korosh Roshanghias; Stefan Schultze-Mosgau
Journal:  Clin Oral Investig       Date:  2016-02-29       Impact factor: 3.573

3.  JMJD3 suppresses tumor progression in oral tongue squamous cell carcinoma patients receiving surgical resection.

Authors:  Yen-Hao Chen; Chang-Han Chen; Chih-Yen Chien; Yan-Ye Su; Sheng-Dean Luo; Shau-Hsuan Li
Journal:  PeerJ       Date:  2022-07-13       Impact factor: 3.061

Review 4.  Clinicopathological prognostic implicators of oral squamous cell carcinoma: need to understand and revise.

Authors:  Kiran B Jadhav; Nidhi Gupta
Journal:  N Am J Med Sci       Date:  2013-12

5.  Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences.

Authors:  Minerva Becker; Arthur D Varoquaux; Christophe Combescure; Olivier Rager; Marc Pusztaszeri; Karim Burkhardt; Bénédicte M A Delattre; Pavel Dulguerov; Nicolas Dulguerov; Eirini Katirtzidou; Francesca Caparrotti; Osman Ratib; Habib Zaidi; Christoph D Becker
Journal:  Eur Radiol       Date:  2017-08-15       Impact factor: 5.315

6.  Salivary MMP-9 in the detection of oral squamous cell carcinoma.

Authors:  A Peisker; G-F Raschke; M-D Fahmy; A Guentsch; K Roshanghias; J Hennings; S Schultze-Mosgau
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-05-01

7.  Ten-Year Outcome of Different Treatment Modalities for Squamous Cell Carcinoma of Oral Cavity

Authors:  Imjai Chitapanarux; Patrinee Traisathit; Nicha Komolmalai; Sompol Chuachamsai; Pichit Sittitrai; Tienchai Pattarasakulchai; Rak Tananuwat; Donyarat Boonlert; Patumrat Sripan; Anak Iamaroon
Journal:  Asian Pac J Cancer Prev       Date:  2017-07-27

8.  The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases.

Authors:  Bo Wang; Shu Zhang; Kai Yue; Xu-Dong Wang
Journal:  Chin J Cancer       Date:  2013-04-19

Review 9.  Functional MRI for Treatment Evaluation in Patients with Head and Neck Squamous Cell Carcinoma: A Review of the Literature from a Radiologist Perspective.

Authors:  Roland P Nooij; Jan J Hof; Peter Jan van Laar; Anouk van der Hoorn
Journal:  Curr Radiol Rep       Date:  2018-01-22

10.  TRKB tyrosine kinase receptor is a potential therapeutic target for poorly differentiated oral squamous cell carcinoma.

Authors:  Kazumasa Moriwaki; Yusuke Ayani; Hiroko Kuwabara; Tetsuya Terada; Ryo Kawata; Michio Asahi
Journal:  Oncotarget       Date:  2018-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.